Eli Lilly and Co
SWB:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
Z
|
Zalando SE
DUS:ZAL
|
DE |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
Adidas AG
F:ADS1
|
DE |
|
M
|
Mastercard Inc
DUS:M4I
|
US |
|
Iberdrola SA
MAD:IBE
|
ES |
|
C
|
China Resources Land Ltd
F:CHZ
|
HK |
|
H
|
Hisense Home Appliances Group Co Ltd
SWB:GKE
|
CN |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
|
H
|
Hongkong Land Holdings Ltd
XMUN:HLH
|
BM |
|
L
|
Lenovo Group Ltd
XMUN:LHL
|
CN |
|
Prosus NV
F:1TY
|
NL |
|
A
|
AstraZeneca PLC
SWB:ZEG
|
UK |
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
|
M
|
Merck & Co Inc
DUS:6MK
|
US |
|
Fubon Financial Holding Co Ltd
TWSE:2881
|
TW |
|
C
|
Campbell's Co
F:CSC
|
US |
|
Hitachi Ltd
TSE:6501
|
JP |
|
C
|
CLEANTEK Industries Inc
XTSX:CTEK
|
CA |
|
E
|
EDP SA
XMUN:EDP
|
PT |
|
N
|
Nine Dragons Paper (Holdings) Ltd
OTC:NDGPY
|
HK |
|
Meridian Mining UK Societas
TSX:MNO
|
UK |
|
Deutsche Boerse AG
XETRA:DB1
|
DE |
|
Walmart Inc
MIL:1WMT
|
US |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
372.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
361.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 53.1B USD. This includes both short-term (5.3B USD) and long-term (47.9B USD) debt.
You can find a full breakdown on its Balance Sheet.